Shui Cao  M.D.
Vice Director

Dr. Cao specializes in the diagnosis and treatment of common tumors, including lung cancer, malignant melanoma, urinary system tumors, gynecological tumors, gastrointestinal tumors and sarcoma and other malignant tumors. the domestic and international developments of this major, develop a number of new anti-tumor biotherapy technologies, and develop comprehensive anti-tumor therapy based on biotherapy and chemotherapy. CIK cells for advanced renal cancer, DC tumor vaccine for metastatic malignant melanoma, non-myeloablative allogeneic hematopoietic stem cell transplantation for high-risk breast cancer, NK cells for advanced ovarian cancer and specific GMV vaccine for malignant tumors.

Social Titels:

Member of clinical application committee of medical biotechnology, China medical biotechnology association
Member of standing committee of biotherapy clinical specialty committee of Chinese research hospital association
Member of tianjin chemotherapy committee of Chinese anti-cancer association
Evaluation expert of national natural science foundation of China
Member of tianjin labor capacity appraisal committee
Expert of degree evaluation committee of Ministry of Education